NF-κB activation as a pathological mechanism of septic shock and inflammation | American Journal of Physiology-Lung Cellular and Molecular Physiology
Can NF-B Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View
Frontiers | Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells | PLOS ONE
Roles for NF-κB in nerve cell survival, plasticity, and disease | Cell Death & Differentiation
Curcumin Blocks Cytokine-Mediated NF-κB Activation and Proinflammatory Gene Expression by Inhibiting Inhibitory Factor I-κB Kinase Activity | The Journal of Immunology
NF-κB - Wikipedia
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism | PNAS
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients | SpringerLink
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
NF-kB inhibitors and activators | Abcam
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Multiple Facets of NF-κB in the Heart | Circulation Research
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
Inhibition of Nuclear Factor Kappa B (NF-κB):
